Stanley-Laman Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.13M Sell
144,019
-409
-0.3% -$8.88K 0.46% 98
2025
Q1
$3.5M Buy
+144,428
New +$3.5M 0.54% 81